[CLSTR]
< Back to situations

[ORGANIZATION]

AIFA

Featured in 43 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT]

Italy influenza, COVID-19 and RSV vaccination rollout

22 clusters · 202 sources · last updated

Latest: Italy launches regional vaccination campaigns in Marche and Molise

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway following preparations in September. Ahead of the October rollout, the Italian Medic

[ACTIVE] [HEALTH] [IT] [FR] [ES]

Italy weather: transition to severe autumn storms

89 clusters · 1271 sources · last updated

Latest: Polar vortex weakening could bring cold weather to Italy

Italy is transitioning from unseasonably mild weather toward significant autumnal instability. Following an exceptionally hot summer, stability provided by the Azores High proved temporary as Atlantic perturbations moved

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1158 sources · last updated

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema

[ACTIVE] [HEALTH] [US] [DE] [IT]

Clinical applications and access of CAR-T and myeloma cell/m

20 clusters · 71 sources · last updated

Latest: Medical advancements in immunotherapy and autoimmune treatments

CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant

[ACTIVE] [HEALTH] [ES] [PA] [AR]

Global RSV vaccine and antibody rollout expands

44 clusters · 159 sources · last updated

Latest: Canadian provinces implement varying RSV vaccine coverage for 2026

Global RSV immunization and antibody rollouts continue to expand, showing significant clinical impact. In the UK, maternal vaccination led to a 50% reduction in intensive care or high dependency unit admissions for infan

[ACTIVE] [HEALTH] [IT]

AIFA pharmaceutical innovation and evaluation discussions

2 clusters · 10 sources · last updated

Latest: AIFA President Nisticò discusses pharmaceutical innovation and drug authorization

The Italian Medicines Agency (AIFA) has initiated institutional dialogues focused on the value of pharmaceutical innovation and its impact on the Italian National Health Service. During a conference in Genoa, discussions

[ACTIVE] [BUSINESS] [NL] [DK] [IT]

Bedrocan bankruptcy and impact on European cannabis supply

4 clusters · 9 sources · last updated

Latest: Bedrocan bankruptcy threatens medical cannabis supplies in Italy

Bedrocan, the sole supplier of medicinal cannabis in the Netherlands since 2003, has been formally declared bankrupt by the District Court of the Northern Netherlands. The family-owned company, operated by the Erkelens f

[ACTIVE] [HEALTH] [US] [IT] [GR]

FDA approves Rasonque; EMA recommends for pancreatic cancer

44 clusters · 321 sources · last updated

Latest: Pancreatic cancer: New research and treatment developments in Greece

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

[ACTIVE] [HEALTH] [IT]

Italian pharmaceutical spending and supply chain stability

3 clusters · 38 sources · last updated

Latest: Italian pharmaceutical spending reaches €6.78 billion in Q1 2026

The Italian Medicines Agency (AIFA) has released reports detailing fiscal and structural challenges within the national pharmaceutical sector. Earlier monitoring from early 2026 revealed a significant spending deficit in

[QUIET] [HEALTH] [DE] [IT] [US]

Daraxonrasib development for pancreatic cancer

2 clusters · 5 sources · last updated

Latest: EMA recommends Daraxonrasib for advanced pancreatic cancer treatment

In September 2026, Felice Antonio Spaccavento, a health official in the Puglia region of Italy, formally requested that the Italian Medicines Agency (AIFA) accelerate access to the targeted therapy daraxonrasib. The requ

[QUIET] [HEALTH] [IT]

Medical and oncology developments in Italy

2 clusters · 24 sources · last updated

Latest: Italy medical experts report advancements in cancer therapies and women's health

Medical congresses and health discussions in Italy have focused on advancements in oncology and women’s health. Early reports highlighted multidisciplinary approaches to breast and prostate cancer care, emphasizing innov

[QUIET] [HEALTH] [GR] [IT] [US]

Multiple myeloma treatment regulatory approvals

2 clusters · 16 sources · last updated

Latest: AIFA approves belantamab mafodotin for multiple myeloma in Italy

Regulatory authorities have granted approvals for new multiple myeloma treatments in the United States and Italy. In September 2026, the US Food and Drug Administration (FDA) issued accelerated approval for iberdomide.

[QUIET] [HEALTH] [IT] [EU]

Cardiovascular health awareness and prevention initiatives

8 clusters · 111 sources · last updated

Latest: Cardiovascular prevention events held in Cecina and Macerata

Efforts to promote cardiovascular health and healthcare sustainability in Italy continue through a combination of policy, clinical research, and community-level initiatives. Institutional discussions in Rome have reinfor

[QUIET] [HEALTH] [IT]

Italian healthcare service and patient rights updates

4 clusters · 51 sources · last updated

Latest: Italy healthcare: Rheumatology initiatives and regional medical crises

Italian health authorities continue to implement measures to expand pharmacy roles and clarify patient rights. New organizational guidelines from AGENAS aim to utilize pharmacies as technical-logistical hubs for telemedi

[QUIET] [POLITICS] [IT]

Basilicata confirms Oct 16 start for pharmaceutical fee

5 clusters · 15 sources · last updated

Latest: Basilicata approves new pharmaceutical co-payment exemptions

Following the implementation of the 2.50 euro pharmaceutical co-payment on September 1, 2026, the Basilicata region has entered a period of heightened social and political tension. While the regional government maintains

[QUIET] [HEALTH] [IT]

Medical advancements and drug approvals in Italy

2 clusters · 23 sources · last updated

Latest: AIFA approves Mirikizumab reimbursement for Crohn's disease in Italy

Medical developments in Italy have recently focused on advancements in respiratory medicine and gastroenterology. During the XXVII National Congress of the Italian Society of Pulmonology (SIP/IRS) in Rome, experts discus

[QUIET] [HEALTH] [CN] [EU] [IT]

Upadacitinib expanded approval for skin and arthritis

4 clusters · 22 sources · last updated

Latest: European Commission approves upadacitinib for three immune-mediated diseases

Clinical trials for the Janus kinase (JAK) inhibitor upadacitinib have demonstrated success in treating severe alopecia areata by blocking inflammatory signals via the JAK/STAT pathway. Research indicates that up to 23 p

Also covered in